• 1
    Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343:1703.
  • 2
    Payne CM, Glasser L, Tischer ME et al. Programmed cell death of the normal human neutrophil: an in vitro model of senescence. Microsc Res Tech 1994; 28:32744.
  • 3
    Homburg CHE & Roos D. Apoptosis of neutrophils. Curr Opin Hematol 1996; 3:949.
  • 4
    Iwai K, Miyawaki T, Takizawa T et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994; 84:12018.
  • 5
    Liles WC & Klebanoff SJ. Regulation of apoptosis in neutrophils-Fas track to death? J Immunol 1995; 155:328991.
  • 6
    Brown SB & Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol 1999; 162:4805.
  • 7
    Savill J & Haslett C. Granulocytes. In: WinkerJD, ed. Apoptosis and inflammation. Progress in inflammation research. Basel, Switzerland: Birkhäuser, 1999.
  • 8
    Nagata S. Apoptosis by death factor. Cell 1997; 88:35565.
  • 9
    Chuang PI, Yee E, Karsan A, Winn RK, Harlan JM. A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils. Biochem Biophys Res Commun 1998; 249:3615.
  • 10
    Weinmann P, Gaehtgens P, Walzog B. Bcl-Xl- and Bax-alpha-mediated regulation of apoptosis of human neutrophils via caspase-3. Blood 1999; 93:310615.
  • 11
    Santos-Beneit AM & Mollinedo F. Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells. J Leukoc Biol 2000; 67:71224.
  • 12
    Henson PM & Johnson RB Jr. Tissue injury in inflammation. Oxidants, protease, and cationic protein. J Clin Invest 1987; 79:66974.
  • 13
    Malech HL & Gallin JI. Neutrophils in human diseases. N Engl J Med 1987; 317:68793.
  • 14
    Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997; 61:37580.
  • 15
    Jimenez MF, Watson WG, Parodo J et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997; 132:126370.
  • 16
    Fanning NF, Kell MR, Shorten GD et al. Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock 1999; 11:16774.
  • 17
    Keel M, Steckholzer U, Niederer E, Hartung T, Trentz O, Ertel W. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997; 90:335663.
  • 18
    Matute-Bello G, Liles WC, Radella IIF et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 156:196977.
  • 19
    Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Clinical observation of 50 cases. Jpn J Allergy 1967; 16:178222.
  • 20
    Furusho K, Kamiya T, Nakano H et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; 2:10558.
  • 21
    Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989; 2:1298302.
  • 22
    Takeshita S, Sekine I, Fujisawa T, Yoshioka S. Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease – the pathogenetic role of hematopoietic colony-stimulating factors (GM-CSF, G-GSF). Acta Paediatr Jpn 1990; 32:50814.
  • 23
    Rowe PC, Quinlan A, Luke BKH. Value of degenerative change in neutrophils as a diagnostic test for Kawasaki disease. J Pediatr 1991; 119:3704.
  • 24
    Niwa Y & Sohmiya K. Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis. J Pediatr 1984; 104:5660.
  • 25
    Takeshita S, Nakatani K, Kawase H et al. The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. J Infect Dis 1999; 179:50812.DOI: 10.1086/314600
  • 26
    Japan Kawasaki Disease Research Committee. Diagnostic guidelines of Kawasaki disease, 4th edn, revised. Tokyo Japan: Kawasaki Disease Research Committee, 1984.
  • 27
    Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139:2719.
  • 28
    Kim HY, Lee HG, Kim DS. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease. J Rheumatol 2000; 27:8016.
  • 29
    Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58:30914.
  • 30
    Hachiya O, Takeda Y, Miyata H, Watanabe H, Yamashita T, Sendo F. Inhibition by bacterial lipopolysaccharide of spontaneous and TNF-alpha-induced human neutrophil apoptosis in vitro. Microbiol Immunol 1995; 39:71523.
  • 31
    Castro A, Bemer V, Nobrega A, Coutinho A, Truffa-Bachi P. Administration to mouse of endotoxin from gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur J Immunol 1998; 28:48895.DOI: 10.1002/(sici)1521-4141(199802)28:02<488::aid-immu488>;2-i
  • 32
    Colamussi ML, White MR, Crouch E, Hartshorn KL. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 1999; 93:2395403.
  • 33
    Wang SZ, Smith PK, Lovejoy M, Bowden JJ, Alpers JH, Forsyth KD. The apoptosis of neutrophils is accelerated in respiratory syncytial virus (RSV) -induced bronchiolitis. Clin Exp Immunol 1998; 114:4954.
  • 34
    Larochelle B, Flamand L, Gourde P, Beauchamp D, Gosselin J. Epstein–Barr virus infects and induces apoptosis in human neutrophils. Blood 1998; 92:2919.
  • 35
    Squier MK, Sehnert AJ, Cohen JJ. Apoptosis in leukocytes. J Leukoc Biol 1995; 57:210.
  • 36
    Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 1992; 151:447.
  • 37
    Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992; 121:9246.
  • 38
    Igarashi H, Hatake K, Tomizuka H, Yamada M, Gunji Y, Momoi MY. High serum levels of M-CSF and G-CSF in Kawasaki disease. Br J Haematol 1999; 105:6135.
  • 39
    Watson RW, Rotstein OD, Nathens AB, Parodo J, Marshall JC. Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol 1997; 158:94553.
  • 40
    Watson RW, Redmond HP, Wang JH, Condron C, Bouchier-Hayes D. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 1996; 156:398692.
  • 41
    Smedly LA, Tonnesen MG, Sandhaus RA et al. Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986; 77:123343.
  • 42
    Savill J & Haslett C. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol 1995; 6:38593.
  • 43
    Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997; 3:61420.